Influence of Different Doses of Levofloxacin on Antioxidant Defense Systems and Markers of Renal and Hepatic Dysfunctions in Rats
Table 3
Effects of levofloxacin treatments on plasma lipid profile in rats.
Treatment
Total cholesterol (mg/dL)
HDL-cholesterol (mg/dL)
LDL-cholesterol (mg/dL)
Triglyceride (mg/dL)
Control
68 ± 3.30
38 ± 4.34
4.5 ± 0.5
13.5 ± 0.35
LFX-1
87.8 ± 3.29 (29%)*
51 ± 2.16 (34%)*
6.6 ± 0.8 (23%)*
20 ± 1.0 (54%)*
LFX-2
102 ± 2.21 (50%)*
55 ± 3.30 (45%)*
7.8 ± 0.6 (56%)*
23.5 ± 0.78 (77%)*
LFX-3
113 ± 1.70 (66%)*
58 ± 3.87 (53%)*
9.4 ± 0.7 (83%)*
28 ± 1.7 (115%)*
The values are means ± SD for five rats in each group. *Significantly different from the control, < 0.05. Values in parenthesis represent percentage (%) of the increase.
